Wordt geladen...
Methotrexate for the Treatment of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
Glucocorticoids have been the primary treatment of graft-versus-host disease (GVHD) over the past decade. Complete responses to steroid therapy are usually expected in almost one-third of aGVHD cases and partial response is anticipated in another one-third of patients. However, for those patients no...
Bewaard in:
| Gepubliceerd in: | J Transplant |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Hindawi Publishing Corporation
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4227326/ https://ncbi.nlm.nih.gov/pubmed/25405023 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/980301 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|